nVector Unveils Breakthrough TDP-43 Assay Diluent to Accelerate ALS Research
PHOENIX, AZ – June 12, 2025 – nVector, Inc. a leader in innovative solutions for neurodegenerative disease research, proudly announces
PHOENIX, AZ – June 12, 2025 – nVector, Inc. a leader in innovative solutions for neurodegenerative disease research, proudly announces